Emeis S.A. | Large-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 13.4B
Total Liabilities 11.7B
Shareholders Equity 1.7B
Debt to Equity 6.79

Cash Flow Metrics

Revenue & Profitability Trend

Emeis S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i5.6B5.2B4.7B4.3B3.9B
Cost of Goods Sold i1.1B1.1B939.3M731.8M748.8M
Gross Profit i4.5B4.1B3.7B3.6B3.2B
Gross Margin % i80.0%79.4%79.9%83.0%80.9%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i291.3M303.1M717.0M250.5M138.3M
Total Operating Expenses i291.3M303.1M717.0M250.5M138.3M
Operating Income i4.2M-120.7M-664.3M364.6M426.4M
Operating Margin % i0.1%-2.3%-14.2%8.5%10.9%
Non-Operating Items
Interest Income i15.2M10.0M261.0K433.0K386.0K
Interest Expense i398.9M581.7M334.1M210.5M228.2M
Other Non-Operating Income-----
Pre-tax Income i-360.0M1.4B-4.6B105.8M210.3M
Income Tax i28.6M44.6M-596.5M37.5M52.6M
Effective Tax Rate % i0.0%3.2%0.0%35.5%25.0%
Net Income i-415.5M1.4B-4.0B66.9M159.3M
Net Margin % i-7.4%26.2%-86.0%1.6%4.1%
Key Metrics
EBITDA i718.7M3.6B141.1M1.0B930.4M
EPS (Basic) i-€10,440.00€-3,979.98€64.50€158.38
EPS (Diluted) i-€10,440.00€-3,979.98€60.67€155.83
Basic Shares Outstanding i-129809101182510111821011137
Diluted Shares Outstanding i-129809101182510111821011137

Income Statement Trend

Emeis S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i518.7M645.0M856.4M952.4M888.8M
Short-term Investments i-----
Accounts Receivable i524.0M518.1M455.4M431.6M233.2M
Inventory i16.2M15.6M16.1M15.7M19.8M
Other Current Assets-----
Total Current Assets i1.9B2.4B2.3B2.8B2.4B
Non-Current Assets
Property, Plant & Equipment i11.0B11.3B11.5B10.5B10.9B
Goodwill i4.3B4.3B4.3B6.4B5.9B
Intangible Assets i1.7B1.5B1.6B3.1B2.9B
Long-term Investments398.0K24.2M84.4M0-
Other Non-Current Assets-3.0K--3.0K1.0K1.0K
Total Non-Current Assets i11.5B11.5B12.2B14.3B14.6B
Total Assets i13.4B13.9B14.5B17.1B17.0B
Liabilities
Current Liabilities
Accounts Payable i405.8M502.3M327.0M334.8M310.4M
Short-term Debt i882.2M1.3B8.6B2.2B1.3B
Current Portion of Long-term Debt-----
Other Current Liabilities425.0M424.6M336.4M412.8M422.5M
Total Current Liabilities i2.6B3.1B10.0B3.5B2.6B
Non-Current Liabilities
Long-term Debt i8.0B7.9B4.8B10.0B9.2B
Deferred Tax Liabilities i730.7M662.5M814.0M997.0M1.4B
Other Non-Current Liabilities-2.0K-2.0K-2.0K2.0K
Total Non-Current Liabilities i9.1B8.9B6.0B11.2B10.8B
Total Liabilities i11.7B12.0B16.0B14.7B13.5B
Equity
Common Stock i1.6M1.3B80.9M80.8M80.8M
Retained Earnings i-412.1M1.4B-4.0B65.2M160.0M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.7B1.9B-1.5B2.3B3.5B
Key Metrics
Total Debt i8.9B9.2B13.4B12.1B10.5B
Working Capital i-743.4M-751.5M-7.7B-738.1M-223.2M

Balance Sheet Composition

Emeis S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-415.5M1.4B-4.0B66.9M160.0M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-80.0M-148.2M-262.1M-218.1M-106.6M
Operating Cash Flow i27.4M-467.9M-102.5M677.0M693.9M
Investing Activities
Capital Expenditures i-143.4M-141.0M-136.3M--
Acquisitions i-100.2M-8.2M-28.7M-421.9M-494.4M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-243.7M-149.2M-165.0M-421.9M-988.9M
Financing Activities
Share Repurchases i-----
Dividends Paid i----58.2M-
Debt Issuance i201.3M500.0M3.4B2.3B1.7B
Debt Repayment i-273.2M-972.0M-2.5B-991.9M-933.5M
Financing Cash Flow i318.4M688.1M898.4M1.3B811.0M
Free Cash Flow i328.6M225.1M273.4M753.8M777.7M
Net Change in Cash i102.1M71.0M630.9M1.5B516.0M

Cash Flow Trend

Emeis S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 0.02
Forward P/E -640.50
Price to Book 1.20
Price to Sales 0.37
PEG Ratio -640.50

Profitability Ratios

Profit Margin -7.31%
Operating Margin 0.54%
Return on Equity -23.02%
Return on Assets 0.01%

Financial Health

Current Ratio 0.72
Debt to Equity 514.45
Beta 0.68

Per Share Data

EPS (TTM) €-2.62
Book Value per Share €10.71
Revenue per Share €35.81

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
emeis2.1B0.021.20-23.02%-7.31%514.45
Orpea 2.0B0.100.85704.66%26.07%485.11
Clariene SE 1.6B9.760.43-1.54%-1.16%209.58
Ramsay Générale de 1.1B34.130.99-5.16%-1.55%337.92
Lna Santé S.A 286.3M13.100.917.25%2.71%270.87
EssilorLuxottica 118.0B48.883.076.44%8.74%36.58

Financial data is updated regularly. All figures are in the company's reporting currency.